Micronutrient-supplemented Milk Study in Women of Childbearing Age
1 other identifier
interventional
70
1 country
1
Brief Summary
The purpose of this study is to determine if consuming ANMUM Materna (a fortified milk product) over a 12-week period increases red blood cell folate concentrations in women of childbearing age in Singapore, compared to an equivalent amount of standard (unfortified) milk.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Jun 2013
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
October 19, 2012
CompletedFirst Posted
Study publicly available on registry
October 23, 2012
CompletedStudy Start
First participant enrolled
June 1, 2013
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 1, 2013
CompletedStudy Completion
Last participant's last visit for all outcomes
October 1, 2013
CompletedOctober 11, 2013
October 1, 2013
4 months
October 19, 2012
October 10, 2013
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Increase in red blood cell folate concentration
To determine if consuming ANMUM Materna over a 12-week period increases red blood cell folate concentrations in women of childbearing age in Singapore, compared to an equivalent amount of standard (unfortified) milk.
12 weeks
Secondary Outcomes (3)
Reduction in homocysteine concentration
12 weeks
Increase in plasma folate concentration
12 weeks
Increase in plasma vitamin B12 concentration
12 weeks
Study Arms (2)
ANMUM Materna
ACTIVE COMPARATOR75g milk powder in 400 ml water daily for 12 weeks.
Control
PLACEBO COMPARATOR75g of milk powder in 400 ml water for 12 weeks.
Interventions
Eligibility Criteria
You may qualify if:
- Female 21-35 years old.
- Able to understand the nature and purpose of the study, including potential risks and side effects.
- Willing to consent to study participation and to comply with study requirements.
- Negative Pregnancy test at screening
You may not qualify if:
- Consumption of vitamins and/or mineral supplements known to contain folate 6 months prior.
- Chronic disease.
- Milk and/or lactose-intolerant.
- Pregnancy in the last 12 months, or currently planning a pregnancy.
- Prior history of NTD-affected pregnancy
- Serum Folate deficiency
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Fonterra Research Centrelead
- Changi General Hospitalcollaborator
Study Sites (1)
Changi General Hospital
Singapore, 529889, Singapore
Study Officials
- PRINCIPAL INVESTIGATOR
Magdalin Cheong
Changi General Hospital
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, INVESTIGATOR
- Purpose
- HEALTH SERVICES RESEARCH
- Intervention Model
- PARALLEL
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
October 19, 2012
First Posted
October 23, 2012
Study Start
June 1, 2013
Primary Completion
October 1, 2013
Study Completion
October 1, 2013
Last Updated
October 11, 2013
Record last verified: 2013-10